Kezar Life Sciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KZR and other ETFs, options, and stocks.

About KZR

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD.

CEO

Christopher J. Kirk

CEOChristopher J. Kirk

Employees

Employees55

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2015

Founded2015

Employees

Employees55

KZR Key Statistics

Market cap

34.34M

Market cap34.34M

Price-Earnings ratio

-0.41

Price-Earnings ratio-0.41

Dividend yield

—

Dividend yield—

Average volume

18.27K

Average volume18.27K

High today

$4.73

High today$4.73

Low today

$4.70

Low today$4.70

Open price

$4.73

Open price$4.73

Volume

5.25K

Volume5.25K

52 Week high

$9.18

52 Week high$9.18

52 Week low

$3.62

52 Week low$3.62

Kezar Life Sciences

Why Robinhood?

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. Show more

KZR Key Statistics

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD.